UCC-90478-23735
3 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 212 / MD
- Registered
- 2021-11-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Moderna
-
2021-04-01
Dose 2 — Moderna
-
2021-11-02
Registered in v-safe
-
2021-11-04
Dose 3 — Moderna
- 2021-11-04
-
2021-11-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-13
- 2021-11-18
- 2021-11-27
- 2021-12-02
- 2021-12-11
- 2021-12-16
-
2022-02-05
Survey response — 3 months, dose 3MedDRA: Angiopathy, Pregnancy, Varicose vein, Vascular pain, Vasodilatation — Feeling: GoodFree text: A vericose vein that is experiencing slow flow, pain, and swelling and is being monitored for blood clotting during my last few weeks of pregnancy.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Survey response — 6 months, dose 3MedDRA: Delivery, Thrombosis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Gave birth. Had several blood clots. Continuing to have blood clots.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-07
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-05-10
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Moderna | No |
| 2 | 2021-04-01 | Moderna | No |
| 3 | 2021-11-04 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 11 — 3 months, dose 3
Symptoms: A vericose vein that is experiencing slow flow, pain, and swelling and is being monitored for blood clotting during my last few weeks of pregnancy.
Release 11 — 6 months, dose 3
Symptoms: Gave birth. Had several blood clots. Continuing to have blood clots.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Angiopathy | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Thrombosis | · | · | ✓ |
| SD | Varicose vein | · | · | ✓ |
| SD | Vascular pain | · | · | ✓ |
| SD | Vasodilatation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release